Stargardt's disease

6 total trials MedDRA PT

Filter these 6 trials by phase, country, sponsor and more.

Open in Search →

Safety of stem cells in treatmemt of retinal diseases. Pending

2023-503573-38-00 3 "Retinal degenerative diseases"
A clinical study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SB-007 in Subjects with Stargardt Disease. Pending

2024-519535-42-00 7 "Stargardt Disease"
An Open-label, Multicenter Trial to Assess Safety and Efficacy of a Subretinal Administration of AAVB-039 Pending

2025-522207-15-01 7 "Stargardt Disease (STGD1)"
An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease Pending

2025-522460-33-00 5 "Stargardt Disease"
Phase I/II Follow-up Study of SAR422459 in Patients with Stargardt’s Macular Degeneration Recruitment ended

2024-513501-31-00 4 2013-05-30 "Congenital, hereditary and neonatal diseases"
Phase 3 Study of Tinlarebant in the Treatment in Adolescent Stargardt Subjects Ended

2024-513483-26-00 5 2022-11-28 "Stargardt Disease"

Showing 1–6 of 6 trials